Detalhe da pesquisa
1.
Experimental models of maternal-fetal interface and their potential use for nanotechnology applications.
Cell Biol Int
; 44(1): 36-50, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469205
2.
Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
Exp Parasitol
; 181: 111-118, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28803905
3.
LPS-mediated activation of TLR4 controls Toxoplasma gondii growth in human trophoblast cell (BeWo) and human villous explants in a dependent-manner of TRIF, MyD88, NF-κB and cytokines.
Tissue Cell
; 78: 101907, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36037656
4.
Cyclooxygenase (COX)-2 modulates Toxoplasma gondii infection, immune response and lipid droplets formation in human trophoblast cells and villous explants.
Sci Rep
; 11(1): 12709, 2021 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135407
5.
BEWO trophoblast cells and Toxoplasma gondii infection modulate cell death mechanisms in THP-1 monocyte cells by interference in the expression of death receptor and intracellular proteins.
Tissue Cell
; 73: 101658, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597888
6.
Biogenic Silver Nanoparticles Can Control Toxoplasma gondii Infection in Both Human Trophoblast Cells and Villous Explants.
Front Microbiol
; 11: 623947, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33552033
7.
Increased Toxoplasma gondii Intracellular Proliferation in Human Extravillous Trophoblast Cells (HTR8/SVneo Line) Is Sequentially Triggered by MIF, ERK1/2, and COX-2.
Front Microbiol
; 10: 852, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068920
8.
Cyclooxygenase (COX)-2 Inhibitors Reduce Toxoplasma gondii Infection and Upregulate the Pro-inflammatory Immune Response in Calomys callosus Rodents and Human Monocyte Cell Line.
Front Microbiol
; 10: 225, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30809216